首页>投融资
Gedea Biotech
未公开
Gedea Biotech is focused on developing an antibiotic free treatment for vaginal fungal infections.In December 2017, the company raised SKr 11 million from a share issue
基本信息
-
公司全称Gedea Biotech AB
-
类型
-
产业领域药品研发/制造、生物/化学技术
-
公司人数15人以下
-
地址Medicon Village LUND SKANE 22381; SE; Telephone: +46767765758;
-
联系电话(0) 708-918681
-
邮箱annette.safholm@gedeabiotech.com
-
成立时间2015-01-01
投融资
-
2023-05-24未公开1400万瑞典克朗未透露
-
2023-05-24未公开1400万瑞典克朗未透露
-
2023-04-04未公开300万瑞典克朗Swelife Accelerator
-
2023-04-04未公开300万瑞典克朗Swelife Accelerator
-
2019-05-22捐赠/众筹未透露Swelife Accelerator
-
2019-05-22捐赠/众筹/授予未透露Swelife Accelerator
- 加载更多
相关投融资企业
A轮
LoQus23 is a Dementia Discovery Fund formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.In November 2021, LoQus23 Therapeutics Ltd announced the successful closing of its £7 million extended seed round
上市
OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS).In November 2020, OS Therapies announced the acquisition of all indications for OST-HER2 including Canine.In June 2021 Advaxis Inc licensing agreement with OS Therapies.In April 2021, OS Therapies announced the closing of a $6 million Series A round of funding
上市
Alumis, formerly known as Esker Therapeutics (previously FL2021-001), is focused on developing precision medicines for the potential treatment of autoimmune diseases.In January 2022, the company changed its name from Esker Therapeutics to Alumis
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息